Business Context and Reporting Period
Company: MONRO, INC.
Filing Type: Form 8-K (Current Report)
Date of Report: November 10, 2025
Reporting Period: Event date November 10, 2025; Signed November 14, 2025.
The filing discloses the entry into a material definitive agreement regarding an operational improvement plan.
Key Financial Metrics
This filing does not report standard financial performance metrics such as revenue, profit, cash flow, margins, debt, or liquidity. The only financial figure disclosed is a specific contractual fee.
- Consulting Fee: $2.2 million payable to AlixPartners, LLP for the extended engagement period.
Material Changes
The Company amended its existing consulting agreement with AlixPartners, LLP. Key changes include:
- Extension of Engagement: The term has been extended to December 27, 2025.
- Scope of Work: The next phase focuses on embedding capabilities, transitioning tools, and supporting revenue acceleration efforts.
- Related Party Transaction: The Company's President and CEO, Peter Fitzsimmons, is also a partner and managing director of AlixPartners. He serves as CEO under an engagement letter with AP Services, LLC, an affiliate of AlixPartners.
Guidance, Outlook, and Risks
Management Commentary: The Company is actively pursuing an operational improvement plan in consultation with AlixPartners. The amendment supports the implementation of this plan.
Risks and Contingencies: The filing highlights a related party transaction involving the CEO and the consulting firm. The Company intends to file the full Amendment as an exhibit to its next Quarterly Report on Form 10-Q.
Investor Verification Checklist
- Verify the total cumulative fees paid to AlixPartners since the initial engagement began.
- Review the upcoming Form 10-Q for the full text of the Amendment and detailed scope of work.
- Assess the potential impact of the $2.2 million fee on the Company's operating expenses for the quarter ending December 31, 2025.
- Confirm the status of the operational improvement plan and any interim results expected by the December 27, 2025 deadline.